|
|
|
|
|
SM531-76
|
Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human
|
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
|
|
|
SM531-76
|
Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human
|
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
|
|
|
SM531-74
|
Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human /GRF [His1,Nle27] (1-32) NH2, human
|
His-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-050-Ser-Arg-Gln-Gln-Gly-NH2
|
|
|
SM531-74
|
Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human /GRF [His1,Nle27] (1-32) NH2, human
|
His-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-050-Ser-Arg-Gln-Gln-Gly-NH2
|
|
|
SM531-75
|
Growth Hormone Releasing Factor (1-29) amide, human GRF (1-29) amide, human
|
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
|
|
|
SM531-75
|
Growth Hormone Releasing Factor (1-29) amide, human GRF (1-29) amide, human
|
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
|
|
|
SM534-29
|
Growth Hormone Releasing Factor(1-44), porcine GRF (1-44), porcine
|
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Ar g-Val-Arg-Leu-NH2
|
|
|
SM534-29
|
Growth Hormone Releasing Factor(1-44), porcine GRF (1-44), porcine
|
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Ar g-Val-Arg-Leu-NH2
|
|
|
SM870-10
|
H.I.V. -1 Protease Substrate
|
Acetyl-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2
|
|
|
SM732-35
|
Hepatitis C Virus NS3 Protease Substrate, fluorogenic
|
Acetyl-Glu-Glu-Val-Val-Ala-Cys-Amino-methylcoumaride
|
|
|
SM732-35
|
Hepatitis C Virus NS3 Protease Substrate, fluorogenic
|
Acetyl-Glu-Glu-Val-Val-Ala-Cys-Amino-methylcoumaride
|
|
|
SM732-36
|
Herpes Virus Inhibitor 1
|
Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-OH
|
|
|
SM872-39
|
Herpes Virus Inhibitor 2
|
Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu-OH
|
|
|
SM870-26
|
HIV Envelope Peptide GP 120, (307-330)
|
Asn-Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-Ile-Gly-OH
|
|
|
SM870-15
|
HIV Substrate IV
|
Lys-Ala-Arg-Val-NorLeu-p-NO2-Phe-Glu-Ala-NorLeu-NH2
|
|
|
SM870-15
|
HIV Substrate IV
|
Lys-Ala-Arg-Val-NorLeu-p-NO2-Phe-Glu-Ala-NorLeu-NH2
|
|
|
SM732-10
|
HIV-TAT (48-57) JNK Inhibitor I
|
Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Pro-NH2
|
|
|
SM640-52
|
Humanin, human
|
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH
|
|
|
SM640-52
|
Humanin, human
|
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH
|
|
|
SM548-19
|
KISS (107-121)
|
Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM548-17
|
KISS (112-121)
|
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM548-17
|
KISS (112-121)
|
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM548-21
|
KISS-1 (125-144)
|
Glu-Ala-Ala-Pro-Gly-Asn-His-Gly-Arg-Ser-Ala-Gly-Arg-Gly-Trp-Gly-Ala-Gly-Ala-Gly-Gln-OH
|
|
|
SM548-11
|
KISS-1 (58-65)
|
Pro-Ala-Ala-Thr-Ala-Arg-Leu-Ser-OH
|
|
|
SM548-13
|
KISS-1 (68-80)
|
Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-OH
|
|
|
SM548-14
|
KISS-1 (68-91)
|
Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Arg-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-OH
|
|
|
SM548-12
|
KISS-1 (94-121)
|
Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM548-12
|
KISS-1 (94-121)
|
Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM271-35
|
Leumorphin (human) (Preproenkephalin B 226-254)
|
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-Arg-Ser-Gln-Glu-Asp-Pro-Asn-Ala-Tyr-Ser-Gly-Glu-Leu-Phe-Asp-Ala-OH
|
|
|
SM271-35
|
Leumorphin (human) (Preproenkephalin B 226-254)
|
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-Arg-Ser-Gln-Glu-Asp-Pro-Asn-Ala-Tyr-Ser-Gly-Glu-Leu-Phe-Asp-Ala-OH
|
|
|
SM550-44
|
LH-RH [D-Ala6]
|
Glp-His-Trp-Ser-Tyr-020-Leu-Arg-Pro-Gly-NH2
|
|
|
SM550-46
|
LH-RH [D-Lys6]
|
Glp-His-Trp-Ser-Tyr-051-Leu-Arg-Pro-Gly-NH2
|
|
|
SM551-46
|
LH-RH [D-Lys6] Free Acid
|
Glp-His-Trp-Ser-Tyr-051-Leu-Arg-Pro-Gly-OH
|
|
|
SM550-45
|
LH-RH [D-Phe2,D-Ala6]
|
Glp-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2
|
|
|
SM557-45
|
LH-RH [Hyp9]
|
Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Hyp-Gly-NH2
|
|
|
551-27
|
LH-RH Free Acid
|
Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-OH
|
|
|
SM558-39
|
LH-RH II alligator, chicken
|
Glp-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2
|
|
|
SM361-26
|
Locustapyrokinin [Glu6], Locusta Migratoria
|
Glp-Asp-Ser-Gly-Asp-Glu-Trp-Pro-Gln-Gln-Pro-Phe-Val-Pro-Arg-Leu-NH2
|
|
|
SM361-25
|
Locustapyrokinin [Glu6], Locusta Migratoria
|
Glp-Asp-Ser-Gly-Asp-Gly-Trp-Pro-Gln-Gln-Pro-Phe-Val-Pro-Arg-Leu-NH2
|
|
|
SM855-46
|
Metalloendopeptidase Substrate
|
2-aminobenzoyl-Ala-Gly-Leu-Ala-p-nitro-benzylamide
|
|
|
SM855-46
|
Metalloendopeptidase Substrate
|
2-aminobenzoyl-Ala-Gly-Leu-Ala-p-nitro-benzylamide
|
|
|
SM548-25
|
Metastin, KISS -1 (68-121)
|
Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Arg-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-As p-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM548-25
|
Metastin, KISS -1 (68-121)
|
Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Arg-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-As p-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
|
|
|
SM882-10
|
MG-115 / ASD 4955 / Potent Reversible Proteasome Inhibitor
|
Z-Leu-Leu-NorVal-Aldehyde
|
|
|
SM882-11
|
MG-132 / Potent Reversible and Cell-permeable Proteasome Inhibitor
|
Z-Leu-Leu-Leu-Aldehyde
|
|
|
SM868-44
|
MMP - 8 Substrate
|
2-4Dinitrophenyl-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH
|
|
|
SM868-44
|
MMP - 8 Substrate
|
2-4Dinitrophenyl-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH
|
|
|
SM868-30
|
MMP 13 Substrate, fluorogenic
|
7-Methoxycoumarin-4acetyl-Pro-CyclohexylAla-Gly-NorVal-His-Ala-3-DNP-L-(2-3)-Diaminopropionic acid-NH2
|
|
|
SM868-42
|
MMP 14 Substrate Stomelysine-3
|
7-Methoxycoumarin-4acetyl-Pro-Leu-Ala-Cys-(sS-MeoBzl)-Trp-Ala-Arg-3-DNP-L-(2-3)-Diamino-propionic acid-NH2
|
|
|
SM868-42
|
MMP 14 Substrate Stomelysine-3
|
7-Methoxycoumarin-4acetyl-Pro-Leu-Ala-Cys-(sS-MeoBzl)-Trp-Ala-Arg-3-DNP-L-(2-3)-Diamino-propionic acid-NH2
|
|
|
SM865-10
|
MMP 2 / MMP 9 Substrate
|
2-4Dinitrophenyl-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH
|
|
|
SM868-20
|
MMP 2 Substrate, fluorogenic
|
7-Methoxycoumarin-4acetyl-Pro-Leu-Ala-NorVal-3-DNP-L-(2-3)-Diaminiopropionic acid-Ala-Arg-NH2
|
|
|
SM868-20
|
MMP 2 Substrate, fluorogenic
|
7-Methoxycoumarin-4acetyl-Pro-Leu-Ala-NorVal-3-DNP-L-(2-3)-Diaminiopropionic acid-Ala-Arg-NH2
|
|
|
SM868-75
|
MMP Inhibitor I
|
4-aminobenzoyl-Gly-Pro-D-Leu-D-Ala-Hydroxamide
|
|
|
SM868-75
|
MMP Inhibitor I
|
4-aminobenzoyl-Gly-Pro-D-Leu-D-Ala-Hydroxamide
|
|
|